logo
logo
AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + real-time funding intelligence
✓Never see duplicates in your feed
INDUSTRY FIRST

Lumicks Raises $93 Million In Series D Financing

Apr 16, 2021•over 4 years ago

Amount Raised

$93 Million

Round Type

series d

Amsterdam

Description

LUMICKS, a leading, next-generation life science tools company that develops highly innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, announced the completion of a $93 million Series D preferred share financing.

Company Information

Company

Lumicks

Location

Amsterdam, New York, United States

About

LUMICKS is a leading life science tools company that develops equipment for Dynamic Single-Molecule and Cell Avidity analysis, two rapidly emerging areas in biology research and immuno-oncology. Built upon innovative technologies, such as optical tweezers (Nobel Prize for Physics 2018) and STED super-resolution (Nobel Prize for Chemistry 2014), LUMICKS tools facilitate the understanding of life to the smallest detail.

Company News

(10 articles)
Fri, 11 Oct 2024 07:00:00 GMT

EU backs Dutch scaleup Lumicks to fast-track discovery of cancer treatments - The Next Web

Tue, 20 Aug 2024 07:00:00 GMT

Differential dynamics specify MeCP2 function at nucleosomes and methylated DNA - Nature

Mon, 19 Apr 2021 07:00:00 GMT

Lumicks snags $93M for its molecular tweezers and cell therapy hardware - Fierce Biotech

Wed, 15 Dec 2021 08:00:00 GMT

LUMICKS Welcomes World-Renowned Scientists and Business Executives to Scientific Advisory Board - PR Newswire

Fri, 18 Jun 2021 07:00:00 GMT

Generation of versatile ss-dsDNA hybrid substrates for single-molecule analysis - ScienceDirect.com

Thu, 28 Jun 2018 07:00:00 GMT

AstraZeneca launches Cambridge partnership with Lumicks to visualize individual DNA, drug molecules - Fierce Biotech

Wed, 23 Nov 2022 08:00:00 GMT

Smc5/6’s multifaceted DNA binding capacities stabilize branched DNA structures - Nature

Thu, 05 Oct 2023 07:00:00 GMT

Negative DNA supercoiling induces genome-wide Cas9 off-target activity - ScienceDirect.com

Sat, 09 Jul 2022 07:00:00 GMT

Chromatin sequesters pioneer transcription factor Sox2 from exerting force on DNA - Nature

Thu, 06 Apr 2023 07:00:00 GMT

Head-on and co-directional RNA polymerase collisions orchestrate bidirectional transcription termination - ScienceDirect.com

FundzWatch™ Score

83
Medium Activity

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech